[6-K] Can-Fite BioPharma Ltd. Current Report (Foreign Issuer)

Can-Fite BioPharma Ltd. adjourned its Special General Meeting of Shareholders due to lack of quorum and will reconvene on Monday, November 10, 2025 at 3:00 p.m. (Israel time) at the company’s offices, 26 Ben Gurion Street, Ramat Gan, Israel.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

6-K

Rhea-AI Filing Summary

Can-Fite BioPharma Ltd. adjourned its Special General Meeting of Shareholders due to lack of quorum and will reconvene on Monday, November 10, 2025 at 3:00 p.m. (Israel time) at the company’s offices, 26 Ben Gurion Street, Ramat Gan, Israel.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 11/03/2025 - 04:15 PM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

Under the Securities Exchange Act of 1934

For the Month of November 2025

001-36203

(Commission File Number)

CAN-FITE BIOPHARMA LTD.

(Exact name of Registrant as specified in its charter)

26 Ben Gurion Street

Ramat Gan 5257346 Israel

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

On November 3, 2025, Can-Fite BioPharma Ltd. (the “Company”) convened a Special General Meeting of Shareholders (the “Meeting”). However, Meeting was adjourned for one week to the same day, time and place due to lack of quorum. Accordingly, the Meeting will be reconvened on Monday, November 10, 2025 at 3:00 p.m., Israel time at the Company’s offices located at 26 Ben Gurion Street, Ramat Gan, Israel.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: November 3, 2025	By:	/s/ Motti Farbstein
		Motti Farbstein
		Chief Executive Officer and Chief Financial Officer

Source: View Original Filing on SEC EDGAR

[6-K] Can-Fite BioPharma Ltd. Current Report (Foreign Issuer)

Rhea-AI Filing Summary

Keep reading

More on CANF

Trending in the feed